Is Pfizer A Good Stock To Buy -

: The stock is currently trading at a forward price-to-earnings (P/E) ratio of roughly 9.3x to 9.4x . This is well below its five-year mean and significantly cheaper than industry peers like Eli Lilly or Novo Nordisk.

: Pfizer is aggressively re-entering the weight-loss market through acquisitions like Metsera . In 2026, it plans to initiate 15 new obesity drug trials, aiming to compete in a market currently dominated by GLP-1 leaders. The Case for Caution: Revenue Headwinds is pfizer a good stock to buy

: Following its $43 billion acquisition of Seagen, Pfizer is now a powerhouse in oncology. Cancer-fighting drugs now account for roughly 27% of total revenue , with the company aiming for eight blockbuster oncology medicines by 2030. : The stock is currently trading at a

Is Pfizer a Good Stock to Buy? (2026 Analysis) As we move through April 2026, many investors are asking if is a bargain or a value trap. After a volatile few years following the pandemic, the pharmaceutical giant is undergoing a massive structural transition. In 2026, it plans to initiate 15 new